Vyome Holdings, Inc
HIND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001427570
No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Vyome Holdings, Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −2 vs. Q3 2021
- Shares held
- 1.16M
- +513.0K (+78.9%) vs. Q3 2021
- Total value
- $1.91M
- +$34.0K (+1.8%) vs. Q3 2021
- New holders
- 3
- 7 more added
- Sold out
- 5
- 2 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HIND on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $296.5K |
| Q1 2026 | 9 | $198.3K |
| Q4 2025 | 8 | $322.3K |
| Q3 2025 | 5 | $125.4K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $1 |
| Q4 2024 | 1 | $13 |
| Q3 2024 | 2 | $24 |
| Q2 2024 | 16 | $73.3K |
| Q1 2024 | 18 | $49.1K |
| Q4 2023 | 15 | $108.3K |
| Q3 2023 | 17 | $134.7K |
| Q2 2023 | 11 | $153.5K |
| Q1 2023 | 13 | $370.3K |
| Q4 2022 | 10 | $12.2K |
| Q3 2022 | 23 | $237.0K |
| Q2 2022 | 19 | $744.0K |
| Q1 2022 | 17 | $1.45M |
| Q4 2021 | 15 | $1.91M |
| Q3 2021 | 18 | $1.90M |
| Q2 2021 | 15 | $5.23M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Vyome Holdings, Inc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 503,615 | $826.0K | 0.00% | +448,239+809.4% | Added |
| Geode Capital Management, LLC | 225,696 | $370.0K | 0.00% | +156,307+225.3% | Added |
| Price T Rowe Associates Inc | 170,900 | $280.0K | 0.00% | +35,200+25.9% | Added |
| Susquehanna Fundamental Investments, LLC | 125,300 | $205.0K | 0.01% | +30,200+31.8% | Added |
| Northern Trust Corp | 33,426 | $55.0K | 0.00% | +33,426 | New |
| Millennium Management LLC | 33,713 | $55.0K | 0.00% | +33,713 | New |
| Virtu Financial LLC | 21,135 | $35.0K | 0.00% | −50,546−70.5% | Reduced |
| State Street Corp | 19,600 | $32.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 15,729 | $26.0K | 0.00% | +15,607+12,792.6% | Added |
| Signaturefd, LLC | 8,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 3,959 | $6.00K | 0.00% | +2,444+161.3% | Added |
| Morgan Stanley | 1,327 | $2.00K | 0.00% | −103,938−98.7% | Reduced |
| BlackRock Inc. | 897 | $1.00K | 0.00% | +897 | New |
| Wells Fargo & Company | 126 | $0 | 0.00% | +84+200.0% | Added |
| Group One Trading, L.P. | 112 | $0 | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −40,255−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −26,951−100.0% | Sold out |
| Sassicaia Capital Advisers LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −9,595−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,842−100.0% | Sold out |
| Mid Atlantic Financial Management Inc | – | – | – | – | Not filed |